Media / Releases

Algenist Debuts Advanced Anti-Aging Repairing Oil

Brand’s first product to feature Solazyme’s advanced Microalgae Oil is on store shelves internationally August 8th at Sephora

SAN FRANCISCO, Calif. – August 8, 2013 – Algenist, a leading anti-aging skincare brand, today announced that its new product, Advanced Anti-Aging Repairing Oil, is now available internationally on store shelves at Sephora. The new anti-aging serum is the first commercial product to feature Solazyme’s Microalgae Oil. The patent-pending advanced Microalgae Oil was developed by Solazyme, a renewable oil and bioproducts company.  In addition to Sephora and Sephora inside jcpenney, the new product can be found at Space NK, QVC, Sephora.com and Algenist.com.

The Advanced Anti-Aging Repairing Oil is formulated with patent-pending Microalgae Oil, an ingredient rich in Oleic Acid, a compound naturally produced by the skin; Phycosterols, a precursor to Vitamin D; and Tocopherols, which offer powerful antioxidant functions. Data from independent, third-party in vitro testing of Microalgae Oil showed a 42% increase in cell regeneration and 31% decrease in cell damage versus untreated cells. Additional data from independent, third-party in vivo testing indicated that skin treated with Microalgae Oil was five times more hydrated 24 hours after application versus untreated skin. Customer trial data also indicated that after 10 days of use, the Advanced Anti-Aging Repairing Oil improved the appearance of fine lines and wrinkles, suppleness, and texture for the majority of participants.

“We believe that the scientific formulation of the Advanced Anti-Aging Repairing Oil is unmatched by any other beauty oil on the market, delivering the performance benefits of a serum combined with the unique experience of an oil, all from biotechnology,” said Frederic Stoeckel, Senior Vice President and General Manager of Health Sciences at Solazyme. “Microalgae Oil provide the basis for a truly revolutionary formula that we believe quickly replenishes the skin with essential nutrients, while creating incredible results within as little as 10 days of use.”  

“We’re committed to providing beauty offerings that are backed by incredible innovation, and Algenist’s biotechnology platform has consistently been a brand to deliver the latest in biotechnology,” said Priya Venkatesh, VP/DMM Skincare, Sephora. “Our customers were among the first to experience the skincare benefits of microalgae, and now we’ll again see the remarkable results Algenist’s Advanced Anti-Aging Repairing Oil brings to the skin.”

Follow Us Online:

·       Solazyme.com and Algenist.com

·       Algenist on Facebook

·       Twitter (@Algenist_SF)

About Algenist

Algenist is award-winning skincare brand harnessing the remarkable regenerative properties of microalgae and rooted in breakthrough biotechnology innovation. After a dedicated team of scientists originally tasked with researching renewable energy solutions discovered Alguronic Acid (patented), a powerful regenerative compound produced by microalgae that functions to protect and regenerate the single-celled organism in harsh environmental conditions, it has since become an active ingredient in many of Algenist’s prestige products. The line has since expanded to tap many of the additional benefits brought forth by this remarkable organism and today, the brand remains dedicated to using groundbreaking science to formulate revolutionary skincare innovations poised for any skin type at any age. Committed to proven results, Algenist skincare products undergo extensive 3rd party clinical and consumer testing for scientifically-based efficacy claims. All Algenist products are dermatologist-tested, non-comodogenic, and hypoallergenic.

This press release contains certain forward-looking statements about Algenist and Solazyme, including statements that involve risks and uncertainties concerning: the expected date of the product launch; the attributes of the product; and the results achieved from product use, including the timing thereof. When used in this press release, the words "will", "expects", "intends" and other similar expressions and any other statements that are not historical facts are intended to identify those assertions as forward-looking statements.  Any such statement may be influenced by a variety of factors, many of which are beyond the control of Solazyme, that could cause actual outcomes and results to be materially different from those projected, described, expressed or implied in this press release due to a number of risks and uncertainties.  Potential risks and uncertainties include, among others: Algenist and Solazyme's limited history in commercializing products; implementation risk in deploying new technologies and market acceptance of its products.  Accordingly, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what impact they will have on the results of operations or financial condition of Solazyme.

In addition, please refer to the documents that Solazyme, Inc. files with the Securities and Exchange Commission, including its Quarterly Reports on Form 10-Q, as updated from time to time, for a discussion of these and other risks.  You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this press release.  Solazyme is not under any duty to update any of the information in this press release.